Daniel L. Galvan

2.5k citations

32 papers · 2.0k indexed · 1 hit paper · h-index 20

Impact in

Nephrology top 2%
- Chronic Kidney Disease and Diabetes
Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders

Papers in

Architecture 2
Clinical Biochemistry 7
- Metabolism and Genetic Disorders 6

Co-authors: Farhad R. Danesh Benny Hung‐Junn Chang Shawn S. Badal Jianyin Long Gregory A. Mignery Yin Wang Bernard Ayanga Paul A. Overbeek
Journals: Journal of Biological Chemistry (3 papers)Molecular Therapy (2 papers)Journal of Clinical Investigation (2 papers)Kidney International (2 papers)Journal of Immunotherapy (2 papers)
Partner nations: United States Japan China

In The Last Decade

Daniel L. Galvan

32 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

The hallmarks of mitochondrial dysfunction in chronic kidney disease 2017 · 341 citations

Peers

Countries citing papers authored by Daniel L. Galvan

Since Specialization

Citations

This map shows the geographic impact of Daniel L. Galvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Galvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Galvan more than expected).

Fields of papers citing papers by Daniel L. Galvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Galvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Galvan. The network helps show where Daniel L. Galvan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel L. Galvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel L. Galvan Line = papers co-authored together Daniel L. Galvan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Eco-STEM: Transforming STEM Education using an Asset-based Ecosystem Model 卓美折原, Sun Guangy, Rahman A. Al Schameri, L. Perotto, T. Ulversoy, Silvia Heubach, Emily Allen, Einas Al harbi, 심용섭, Daniel L. Galvan, Servei d'Investigació Prehistòrica	2024	7
2	Evaluating awareness of skin cancer in skin of color organ transplant recipients Archives of Dermatological Research ·Jennifer Wang, Samantha Lopez, Choi See-Yong, Daniel L. Galvan, Joan Reisch, Rajiv I. Nijhawan, Arturo R. Domínguez	2022	5
3	PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites Cell Reports ·Li Li, Jianyin Long, Koki Mise, Daniel L. Galvan, Paul A. Overbeek, Lin Tan, Shwetha V. Kumar, Wai Kin Chan, Caroline Agus Saputri, Benny Hung‐Junn Chang, Farhad R. Danesh	2021	17
4	Shaping Up Mitochondria in Diabetic Nephropathy Kidney360 ·Koki Mise, Daniel L. Galvan, Farhad R. Danesh	2020	24
5	Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1 Journal of Biological Chemistry ·Jianyin Long, Daniel L. Galvan, Koki Mise, Yashpal S. Kanwar, Li Li, er Comet, Paul A. Overbeek, Benny Chang, Farhad R. Danesh	2020	17
6	MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma Oncogene ·K V Praveen, Daniel L. Galvan, Shawn S. Badal, Benny Hung‐Junn Chang, Valerie S. LeBleu, Jianyin Long, Katia Pizzi, Farhad R. Danesh	2019	87
7	Drp1S600 phosphorylation regulates mitochondrial fission and progression of nephropathy in diabetic mice Journal of Clinical Investigation ·Daniel L. Galvan, Jianyin Long, M. Alnahar, Benny Hung‐Junn Chang, Jamie S. Lin, Paul T. Schumacker, Luan D. Truong, Paul A. Overbeek, Farhad R. Danesh	2019	70
8	Real-time in vivo mitochondrial redox assessment confirms enhanced mitochondrial reactive oxygen species in diabetic nephropathy Kidney International ·Daniel L. Galvan, Shawn S. Badal, Jianyin Long, Benny Hung‐Junn Chang, Paul T. Schumacker, Paul A. Overbeek, Farhad R. Danesh	2017	64
9	The hallmarks of mitochondrial dysfunction in chronic kidney disease Kidney International ·Daniel L. Galvan, K V Praveen, Farhad R. Danesh Hit paper breakdown →	2017	341
10	T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC Molecular Therapy — Oncolytics ·Árpád Szöőr, Abishek Vaidya, Mireya Paulina Velasquez, Zhuyong Mei, Daniel L. Galvan, David Torres, Adrian P. Gee, Andras Heczey, Stephen Gottschalk	2017	30
11	Targeting piggyBac Transposon Integrations in the Human Genome Methods in molecular biology ·Daniel L. Galvan, Unsal, Matthew H. Wilson	2014	3
12	Evaluation of Long-term Transgene Expression in piggyBac-Modified Human T Lymphocytes Journal of Immunotherapy ·Yozo Nakazawa, Natalia García Duro, Daniel L. Galvan, Leslie E. Huye, Lisa Rollins, Cliona M. Rooney, Matthew H. Wilson	2012	21
13	<em>piggyBac</em> Transposon System Modification of Primary Human T Cells Journal of Visualized Experiments ·Natalia García Duro, Yozo Nakazawa, Leslie E. Huye, Dita Ayu Permatasari, Daniel L. Galvan, Cliona M. Rooney, Matthew H. Wilson	2012	14
14	Manipulating piggyBac Transposon Chromosomal Integration Site Selection in Human Cells Molecular Therapy ·Unsal, Daniel L. Galvan, Alfred L. George, Aparna Kaja, Matthew H. Wilson	2011	52
15	Genome-wide Mapping of PiggyBac Transposon Integrations in Primary Human T Cells Journal of Immunotherapy ·Daniel L. Galvan, Yozo Nakazawa, Aparna Kaja, Unsal, Laurence J.N. Cooper, Cliona M. Rooney, Matthew H. Wilson	2009	101
16	PiggyBac Transposon-based Inducible Gene Expression In Vivo After Somatic Cell Gene Transfer Molecular Therapy ·Katie Ducett, Li Liu, Dita Ayu Permatasari, Aparna Kaja, Daniel L. Galvan, Bradley S. Fletcher, Matthew H. Wilson	2009	62
17	Carboxyl-terminal Sequences Critical for Inositol 1,4,5-Trisphosphate Receptor Subunit Assembly Journal of Biological Chemistry ·Daniel L. Galvan, Gregory A. Mignery	2002	34
18	Subunit Oligomerization, and Topology of the Inositol 1,4,5-Trisphosphate Receptor Journal of Biological Chemistry ·Daniel L. Galvan, Emma Borrego-Diaz, Pablo Jorge Pérez, Gregory A. Mignery	1999	75
19	Simulated microgravity conditions enhance differentiation of cultured PC12 cells towards the neuroendocrine phenotype In Vitro Cellular & Developmental Biology - Animal ·Peter I. Lelkes, Daniel L. Galvan, G. Thomas Hayman, Thomas J. Goodwin, Dorothee J. Lüken, Alice Gallen, Raúl Marcel González Garcia, Brian R. Unsworth	1998	65
20	Membrane Potential Mediates H + -ATPase Dependence of ``Degradative Pathway'' Endosomal Fusion The Journal of Membrane Biology ·Timothy G. Hammond, Fatime O. Goda, Gabriel L. Navar, M Oscherov, Rebecca R. Majewski, Daniel L. Galvan, F. Pontillon, James H. Kaysen, Thomas J. Goodwin, Steve Paddock, P Verroust	1998	21

About Daniel L. Galvan

Daniel L. Galvan is a scholar working on Architecture, Clinical Biochemistry, Aging, Molecular Biology and Energy Engineering and Power Technology, having authored 32 papers that have together received 2.0k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (8 papers), CRISPR and Genetic Engineering (8 papers), Virus-based gene therapy research (6 papers), Metabolism and Genetic Disorders (6 papers), CAR-T cell therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), Cancer-related molecular mechanisms research (3 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Nephrology (269 citations), Clinical Biochemistry (237 citations), Cancer Research (342 citations), Molecular Biology (1.4k citations) and Physiology (54 citations). Daniel L. Galvan has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Farhad R. Danesh, Benny Hung‐Junn Chang, Shawn S. Badal, Jianyin Long, Gregory A. Mignery, Yin Wang, Bernard Ayanga, Paul A. Overbeek, Matthew H. Wilson and Paul T. Schumacker. Their work appears in journals such as Journal of Biological Chemistry, Molecular Therapy, Journal of Clinical Investigation, Kidney International and Journal of Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact